Did you know that manual document reconciliation between trial systems consumes at least one-third of clinical data managers' and clinical research associates’ time? This means your highly trained professionals are spending their days chasing files between platforms rather than moving science forward. Medable’s TMF Agent takes on the high-volume work of organizing and filing trial documents across studies. Your team reviews, approves, stays in control where it matters, and gets their time back. That shift is a game changer and frees up real strategic capacity. DM this account to learn more! 📥 ________ #clinicalresearch #TMF #clinicaltrials #agenticAI

Come see what's possible in the age of agentic trial operations at Medable.com.

What to learn more and the global race to develop drugs? Check out our CEO @LongmireMD’s research and perspective here: @fredlaunchpdh @HealthXVentures @SapphireVC @cgao @LillyTrials @ScottGottliebMD @BioWorld @FDA

Reta for the win in OSA 👏❤️ @LillyTrials @DaveARicks

Let’s go #ESMO26!

What's next for pharmaceutical innovation? Join Medable CEO @LongmireMD as she moderates the Best Pharmaceutical Product webinar during the 2026 Galien Week of Innovation, bringing together leaders advancing the future of medicine. 📅 October 28 | 10 AM–12 PM ET Learn more: galienfoundation.org/gwi-202… #PrixGalien #PharmaInnovation

Tune in on October 27 as Medable's Alison Holland showcases our Agentic Clinical Development Platform during the Galien Week of Innovation's Best Digital Health Solution webinar. 📅 October 27 | 10 AM–12 PM ET Learn more: galienfoundation.org/gwi-202… #DigitalHealth #PrixGalien

See what Agentic AI looks like in real trials. Watch to learn how AI agents work in clinical operations at scale, with live demonstrations and deployment examples across digital data flow, clinical monitoring, and TMF management. 👇 medable.com/knowledge-center…

What if the gap between identifying a clinical trial challenge and deploying a working solution could shrink from a year to just months? That's the idea behind the Forward Deployed Engineer (FDE), a role that's become central to improving operational clinical development with AI. Read from Medable's Nick Fuentes on his role as an FDE here: medable.com/knowledge-center… #Agentic AI #AI #clinicaltrials #clinical research

Medable joins key leaders from @AnthropicAI, @Bayer, @TakedaPharma, @bmsnews, and more for the Endpoints AI Day Summit on October 14th. Join Medable and learn how clinical monitoring agents are being used today to connect fragmented workflows, surface the signals that matter, and give study teams more time to focus on their sites. Register here ⬇️ events.endpoints.news/aiday2…

Up to $21 million in added value per oncology development program. In The Scientist, Medable's Pamela Tenaerts and Tufts Center for the Study of Drug Development's Ken Getz discuss the findings and supporting evidence. Read the article: the-scientist.com/ai-clinica… #ClinicalTrials #ClinicalResearch #AI

Heading to @genentech 3rd annual Clinical Trial Innovation Summit? Check out @LongmireMD's presentation, "Beyond Risk-Based: Agentic Oversight in Clinical Trials," and learn how clinical monitoring can move from periodic review to continuous reasoning.

Up to $21 million in added value per oncology development program. In The Scientist, Pamela Tenaerts and Ken Getz discuss the findings and the evidence behind them. Read the article: the-scientist.com/ai-clinica… #ClinicalTrials #ClinicalResearch #AI

Clinical monitoring is entering a new era. And this one moves fast. Medable’s latest monitoring agents work across the day-to-day realities of clinical monitoring: prioritizing site risk, preparing visits, recommending next actions, automating administrative work, and helping CRAs focus their time where human judgment matters most. And we’re already seeing the impact. In two studies, the Clinical Monitoring Agent delivered a 62% reduction in CRA task time in one deployment and a 90% reduction in visit report preparation in another.

This Breast Cancer Awareness Month, we recognize every patient, family, researcher, clinician, and advocate whose life and work are connected to this disease. Because behind every study, every breakthrough, and every day we work to give back to clinical development, there are people hoping for more time and better options. 🩷 At Medable, our mission is to make clinical trials faster, more accessible, and more effective, so promising science can reach the people waiting for it sooner. #BreastCancerAwarenessMonth #ClinicalResearch #ClinicalTrials

Moving fast means constantly solving new problems, building what’s next, and never standing still. ⚡ For Jenn Brown, VP, Product Management, AI Experiences, that pace is what makes working at Medable so interesting. She shares what keeps her energized, the people who make the work fun, and why Medable’s mission to change healthcare and get treatments to patients faster resonates with her. And when it’s time to get stuff done? Old-school Taylor Swift is the soundtrack. 🎶 Watch Jenn’s interview below. 👇 #ClinicalTrials #ClinicalResearch #LifeSciences #Healthcare

AI agents evolve. Medable’s agentic governance evolves with them. Our continuous governance framework monitors agent performance throughout the lifecycle, helping teams identify changes, maintain oversight, and ensure agents continue performing as intended. For clinical development, that means governance that isn’t frozen at deployment. It keeps pace with the agents themselves. Our latest white paper explores how continuous governance enables clinical teams to scale agentic AI with ongoing performance monitoring, control, and traceability. Access it here 👉 bit.ly/4rKjom7 #clinicaltrials #agenticAI #AIgovernance #agents

AI agents evolve. Medable’s agentic governance evolves with them. Our continuous governance framework monitors agent performance throughout the lifecycle, helping teams identify changes, maintain oversight, and ensure agents continue performing as intended. For clinical development, that means governance that isn’t frozen at deployment. It keeps pace with the agents themselves. Our latest white paper explores how continuous governance enables clinical teams to scale agentic AI with ongoing performance monitoring, control, and traceability. Access it here 👉 medable.com/knowledge-center… #clinicaltrials #agenticAI #AIgovernance #agents

As clinical trials extend beyond the traditional site, principal investigators are increasingly responsible for work carried out by people they don’t directly supervise or contract, including local providers, visiting nurses, and remote data collection vendors. These external parties may perform trial activities, but accountability still sits with the investigator. Until now, there has been little practical guidance for navigating that gap. Tomorrow, the MRCT Center and Medable will introduce 4 resources designed to address it: → Optimizing Decentralized Elements in Clinical Trials (DCTs): The sponsor's design tool for determining which activities are appropriate to move off-site. → Proportional Oversight Framework for Clinical Trials with Decentralized Elements: Translates those choices into a site-level approach calibrated to risk, rather than applying the same standard everywhere. → HCP Instruction Sheet: A model template, pre-filled by the sponsor and site, giving local providers clear direction on exactly what is expected of them. → HCP Check-In Questions for Participants: A consistent approach to understanding how participants are doing between visits, including worked responses across nine different scenarios. This webinar will walk through each resource and, importantly, show how they work together to support decentralized trial delivery. Each tool is designed for principal investigators, study coordinators, IRB reviewers, and sponsors incorporating hybrid and digital elements into their studies. Register here to secure your spot: lp.constantcontactpages.com/… ________ #clinicaltrials #clinicalresearch #healthcare #decentralizedtrials

Medable and the MRCT Center announce new resources for sponsors and investigators. These practical tools help determine which trial activities can appropriately take place closer to participants and establish the proportionate oversight, communication, and escalation processes needed to support them. The decentralized model gained traction during the pandemic and has since evolved into a strategic priority for drug developers seeking to improve patient recruitment, retention, and diversity. In fact, trials incorporating decentralized components increased by nearly one-third from 2021 to 2022 alone. 👉 Learn more here: medable.com/newsroom/mrct-ce… ________ #clinicaltrials #clinicalresearch #healthcare #decentralizedtrials